See also this year's filing and all EDGAR filings for this company.
PDF Report 0001690585_2023_Dianthus_Therapeutics_Inc_DE.pdf
Logs
Graph
Absolute values for 0001690585, Dianthus Therapeutics Inc. DE
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 115,602,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,095,000 |
| 3 | remainder_Assets | 24,948,000 |
| 4 | LiabilitiesCurrent | 14,549,000 |
| 5 | LiabilitiesNoncurrent | 26,138,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,761,000 |
| 9 | ResearchAndDevelopmentExpense | 55,141,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 4,440,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -151,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 146,645,000 |
| 1 | Liabilities | 40,687,000 |
| 2 | Expenses | 80,902,000 |
| 3 | Revenues | 4,440,000 |
| 4 | StockholdersEquity | 105,958,000 |
| 5 | NetIncome | -76,462,000 |
| 6 | ComprehensiveNetIncome | -76,537,500 |
| 7 | BaseVar | 136,412,500 |
| 8 | EconomicCapitalRatio | 1.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
